Medtronic plc Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer
Medtronic plc (MDT) reported Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer of $12.00 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-03.
Financial Statements › Income Statement › Other Income
us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer · last filed 2026-09-03
- Medtronic plc revenue from collaborative arrangement, excluding revenue from contract with customer for the quarter ending 2026-07-31 was $12.00M, a 66.67% decline year-over-year.
- Medtronic plc revenue from collaborative arrangement, excluding revenue from contract with customer for the quarter ending 2026-04-24 was $34.00M, a 29.17% decline year-over-year.
- Medtronic plc revenue from collaborative arrangement, excluding revenue from contract with customer for the quarter ending 2026-01-23 was $36.00M, a 28.00% decline year-over-year.
- Medtronic plc revenue from collaborative arrangement, excluding revenue from contract with customer for the quarter ending 2025-10-24 was $37.00M, a 19.57% decline year-over-year.
- Medtronic plc revenue from collaborative arrangement, excluding revenue from contract with customer for fiscal 2026 was $142.00M, a 21.55% decline from fiscal 2025.
- Medtronic plc revenue from collaborative arrangement, excluding revenue from contract with customer for fiscal 2025 was $181.00M, a 4.02% increase from fiscal 2024.
- Medtronic plc revenue from collaborative arrangement, excluding revenue from contract with customer for fiscal 2024 was $174.00M, a 13.86% decline from fiscal 2023.
- Medtronic plc revenue from collaborative arrangement, excluding revenue from contract with customer for fiscal 2023 was $202.00M.
| Period end | Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer 3 month | Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer 6 month | Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer 9 month | Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer 12 month |
|---|---|---|---|---|
| 2026-07-31 | $12.00M 10-Q · filed 2026-09-03 | $46.00M derived: sum of 2 quarters · filed 2026-09-03 | $82.00M derived: sum of 3 quarters · filed 2026-09-03 | $119.00M derived: sum of 4 quarters · filed 2026-09-03 |
| 2026-04-24 | $34.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $70.00M derived: sum of 2 quarters · filed 2026-06-18 | $107.00M derived: sum of 3 quarters · filed 2026-06-18 | $142.00M 10-K · filed 2026-06-18 |
| 2026-01-23 | $36.00M 10-Q · filed 2026-02-24 | $73.00M derived: sum of 2 quarters · filed 2026-02-24 | $108.00M 10-Q · filed 2026-02-24 | $157.00M derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-10-24 | $37.00M 10-Q · filed 2025-11-25 | $73.00M 10-Q · filed 2025-11-25 | $121.00M derived: sum of 3 quarters · filed 2026-09-03 | $171.00M derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-07-25 | $36.00M 10-Q · filed 2026-09-03 | $84.00M derived: sum of 2 quarters · filed 2026-09-03 | $134.00M derived: sum of 3 quarters · filed 2026-09-03 | $180.00M derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-04-25 | $48.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $98.00M derived: sum of 2 quarters · filed 2026-06-18 | $144.00M derived: sum of 3 quarters · filed 2026-06-18 | $181.00M 10-K · filed 2026-06-18 |
| 2025-01-24 | $50.00M 10-Q · filed 2026-02-24 | $96.00M derived: sum of 2 quarters · filed 2026-02-24 | $133.00M 10-Q · filed 2026-02-24 | |
| 2024-10-25 | $46.00M 10-Q · filed 2025-11-25 | $84.00M 10-Q · filed 2025-11-25 | ||
| 2024-07-26 | $38.00M 10-Q · filed 2025-08-26 | |||
| 2024-04-26 | $174.00M 10-K · filed 2026-06-18 | |||
| 2023-04-28 | $202.00M 10-K · filed 2025-06-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B |